Quator

Medicinal product

(Invented) name

Quator

Active substance (s)

Tadalafilis

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE08, Tadalafil

Marketing authorisation holder

Sandoz d.d., Slovėnija

Date of authorisation

2019-07-02

Date of renewal

2023-12-18

Documents

4421_4423 Quator PCS PL 2024 05 05.docx

4421_4423 Pakuotės lapelis 2024 05 05.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

NL/H/4395/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Tadalafilis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105222	91324	1091324	lizdinė plokštelė	N14x1		Receptinis	LT/1/19/4421/004	Netiekiama	-	-	No	-	-
105223	91325	1091325	lizdinė plokštelė	N28x1		Receptinis	LT/1/19/4421/005	Netiekiama	-	-	No	-	-
105224	91326	1091326	lizdinė plokštelė	N84x1		Receptinis	LT/1/19/4421/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-12-18	Perregistruotas
2019-07-02	Registruotas